Bio Path | BPTH - Ebitda





Ebitda Veränderung Datum
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Baxter International USD 309M 756M 2026-03
Bio Path USD -3.21M 631K 2025-03
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09